Aarey Drugs Financials

AAREYDRUGS   56.29  1.60  2.93%   
Financial data analysis helps to double-check if markets are presently mispricing Aarey Drugs Pharmace. We are able to break down and analyze data for twenty-five available fundamental indicators for Aarey Drugs Pharmaceuticals, which can be compared to its peers. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Aarey Drugs to be traded at 67.55 in 90 days. Key indicators impacting Aarey Drugs' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income2.7 M2.8 M
Notably Down
Slightly volatile
  
Understanding current and past Aarey Drugs Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aarey Drugs' financial statements are interrelated, with each one affecting the others. For example, an increase in Aarey Drugs' assets may result in an increase in income on the income statement.

Aarey Drugs Stock Summary

Aarey Drugs competes with State Bank, Life Insurance, HDFC Bank, ICICI Bank, and Reliance Industries. Aarey Drugs is entity of India. It is traded as Stock on NSE exchange.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentIndia Stock View All
ExchangeNational Stock Exchange of India
ISININE198H01019
Business Address107, Sahakar Bhavan,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.aareydrugs.com
Phone91 22 6287 2900
You should never invest in Aarey Drugs without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Aarey Stock, because this is throwing your money away. Analyzing the key information contained in Aarey Drugs' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Aarey Drugs Key Financial Ratios

There are many critical financial ratios that Aarey Drugs' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Aarey Drugs Pharmace reports annually and quarterly.

Aarey Drugs Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets1.9B2.3B2.5B2.9B3.0B1.6B
Other Current Liab75.7M40.0M35.1M56.7M98.5M103.4M
Net Debt174.0M173.8M139.7M370.1M297.6M312.5M
Retained Earnings315.9M381.1M446.5M484.2M531.3M557.8M
Cash4.9M6.4M1.9M7.1M15.9M16.7M
Inventory170.0M184.6M136.8M288.2M719.9M755.9M
Other Current Assets85.1M87.9M337.3M46.0M232.3M137.5M
Total Liab1.0B1.3B1.3B1.7B1.7B939.2M
Total Current Assets1.8B2.2B2.3B2.7B2.8B1.5B
Short Term Debt178.7M180.2M108.2M333.6M281.3M295.3M
Accounts Payable730.4M1.1B1.1B1.3B1.3B835.9M
Net Receivables961.3M1.6B1.4B2.0B1.8B1.1B
Other Liab14.9M14.4M33.7M14.6M16.7M19.9M
Net Tangible Assets865.5M923.5M988.6M1.1B1.3B1.0B
Long Term Debt191.2K0.033.4M43.6M32.2M17.3M
Net Invested Capital1.1B1.2B1.3B1.6B1.6B1.4B
Short Long Term Debt178.7M180.2M141.6M333.6M281.3M205.6M
Net Working Capital810.7M857.7M780.5M1.0B1.1B952.5M

Aarey Drugs Key Income Statement Accounts

201920202021202220232024 (projected)
Total Revenue3.0B3.5B4.9B4.1B4.0B2.7B
Gross Profit99.1M101.0M195.4M104.1M113.0M79.8M
Operating Income63.5M82.3M100.3M66.9M2.8M2.7M
Ebit63.5M82.3M100.3M66.9M28.2M44.2M
Ebitda72.5M91.5M120.1M82.7M45.2M53.8M
Cost Of Revenue2.9B3.4B4.7B4.0B3.8B2.6B
Income Before Tax72.4M83.0M100.3M60.2M53.4M46.5M
Net Income57.9M65.1M65.5M37.7M46.8M34.5M
Income Tax Expense14.5M17.9M34.8M22.4M6.6M12.0M
Interest Expense16.9M23.2M19.1M28.7M43.8M45.9M
Tax Provision14.5M17.9M34.8M22.4M6.6M6.3M
Net Interest Income8.8M(28.3K)(20.0M)(28.7M)(43.8M)(41.6M)
Interest Income26.6M24.3M20.1M26.3M23.7M19.2M

Aarey Drugs Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory42.5M(14.6M)47.8M(151.4M)(58.6M)(55.6M)
Change In Cash1.3M1.5M(4.6M)5.1M8.9M9.3M
Free Cash Flow19.4M26.0M(66.9M)(23.3M)(33.0M)(34.7M)
Depreciation8.9M9.2M19.9M15.7M17.0M9.9M
Other Non Cash Items2.8M7.7M(15.9M)5.9M30.4M32.0M
Capital Expenditures9.2M28.8M22.0M10.4M7.2M6.9M
Net Income72.4M83.0M100.3M60.2M46.8M47.9M
End Period Cash Flow5.0M6.5M1.9M7.1M15.9M9.4M
Investments(9.2M)(28.8M)(22.0M)4.4M(17.0M)(17.9M)
Change To Netincome24.2M17.3M25.5M18.9M21.8M21.8M

Aarey Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aarey Drugs's current stock value. Our valuation model uses many indicators to compare Aarey Drugs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aarey Drugs competition to find correlations between indicators driving Aarey Drugs's intrinsic value. More Info.
Aarey Drugs Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.16  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Aarey Drugs Pharmaceuticals is roughly  6.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aarey Drugs' earnings, one of the primary drivers of an investment's value.

Aarey Drugs Pharmace Systematic Risk

Aarey Drugs' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aarey Drugs volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Aarey Drugs Pharmace correlated with the market. If Beta is less than 0 Aarey Drugs generally moves in the opposite direction as compared to the market. If Aarey Drugs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aarey Drugs Pharmace is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aarey Drugs is generally in the same direction as the market. If Beta > 1 Aarey Drugs moves generally in the same direction as, but more than the movement of the benchmark.

Aarey Drugs Pharmaceuticals Common Stock Shares Outstanding Over Time

Aarey Drugs Thematic Clasifications

Aarey Drugs Pharmaceuticals is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas

Aarey Drugs November 22, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Aarey Drugs help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aarey Drugs Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aarey Drugs Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Aarey Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aarey Drugs's daily price indicators and compare them against related drivers.

Additional Tools for Aarey Stock Analysis

When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.